Arkolith/Insider Trading/ELEV/Form 4

Carruthers R Michael

DirectorElevation Oncology, Inc. (ELEV) · full profile →Form 4 · filed Jul 24, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 23, 2025Disposed to issuer(D)31K—$00
Jul 23, 2025Disposed to issuer(D)35K—$00
Jul 23, 2025Disposed to issuer(D)16K—$00
Jul 23, 2025Disposed to issuer(D)35K—$00
Jul 23, 2025Disposed to issuer(D)47K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-020236) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML